Target intelligence / Profile preview

Reactive oxygen species and electrophilic cytotoxic metabolites (ROS)

Target
ROS
Molecular classification
Reactive molecules, Free radicals, Oxidants, Electrophiles, Other
01

Overview

Reactive oxygen species (ROS) and electrophilic cytotoxic metabolites are highly reactive chemical entities that play dual roles in cellular physiology and pathology. ROS, including superoxide radicals and hydrogen peroxide, are produced during mitochondrial respiration and by enzymes like NADPH oxidase, serving as important signaling molecules at low levels but causing oxidative stress when in excess (NIH, PMC3184498). Electrophilic metabolites are often reactive intermediates formed during the metabolism of drugs or toxins, such as the paracetamol metabolite N-acetyl-p-benzoquinone imine (NAPQI), which can cause cell death by binding to vital proteins and DNA (PubMed, 15922011). Therapeutic intervention typically involves the use of scavengers or antioxidants, such as N-acetylcysteine or Mesna, which chemically neutralize these species or bolster the cell's endogenous detoxification systems (PubChem). While not traditional protein targets like receptors or enzymes, managing the levels of these reactive species is critical in treating conditions ranging from acute drug toxicity to chronic inflammatory and neurodegenerative diseases (StatPearls, NBK459141). These molecules are often monitored via biomarkers of oxidative damage, such as malondialdehyde or 8-hydroxy-2'-deoxyguanosine, to assess the extent of cellular stress (PubMed, 25915737).

Other names
Reactive oxygen speciesROSElectrophilic metabolitesReactive intermediatesOxidantsFree radicalsReactive oxygen species and electrophilic cytotoxic metabolites
02

Mechanism of action

Direct chemical neutralization or scavenging of reactive species and covalent conjugation with electrophilic intermediates to prevent damage to cellular macromolecules.

03

Biological functions

Signal transductionApoptosisImmune responseCell deathOxidative stress inductionOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfectionOther
05

Safety considerations

Disruption of physiological ROS signalingAntioxidant paradoxPotential interference with chemotherapy efficacyPro-oxidant effects at high concentrations
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsReduced-to-oxidized glutathione ratio (GSH/GSSG)

Beyond the preview

Go deeper on Reactive oxygen species and electrophilic cytotoxic metabolites (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and electrophilic cytotoxic metabolites (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call